Myocarditis after BNT162b2 Vaccination in Israeli Adolescents

 https://www.nejm.org/doi/full/10.1056/NEJMc2207270

Our study indicates that BNT162b2 vaccine–induced myocarditis in adolescents appears to be a rare adverse event that occurs predominantly in males after the second vaccine dose. The clinical course appears to be mild and benign over a follow-up period of 6 months, and cardiac imaging findings suggest a favorable long-term prognosis.